<DOC>
	<DOCNO>NCT03090685</DOCNO>
	<brief_summary>Chikungunya fever acute viral disease , transmit mosquito ( Aedes aegypti ) , trigger pain disable rheumatic manifestation . There cure disease , usual treatment direct relieve symptom use analgesic antipyretic . Due risk adverse effect trigger prolonged use analgesic anti-inflammatory drug , use complementary therapy , Auriculotherapy , might safe effective non-pharmacological treatment management Chikungunya symptomatic case . Subjects diagnose Chikungunya undergoing routine treatment receive auricotherapy treatment week , five week . Subjects assess baseline 4 8 week intervention . This study might help understand use Auriculotherapy complementary treatment treatment physical functional symptom individual infect Chikungunya .</brief_summary>
	<brief_title>Effects Auriculotherapy Pain Functional Capacity Individuals With Chikungunya Fever</brief_title>
	<detailed_description>Objectives study 1 . To evaluate effectiveness Auriculotherapy management pain functional capacity symptomatic individual Chikungunya fever . 2 . To evaluate effect Auriculotherapy intensity pain , limitation mobility , perception disability physical capacity . 3 . Investigate effect Auriculotherapy pain medication use . Place study population : Subjects diagnose Chikungunya Fever recruit convenience basic care city Fortaleza-CE , Brazil , order evaluate treat researcher 's team . Procedures intervention : Subjects evaluate initial time research , 4 8 week intervention . The description procedure follow guideline Consolidated Standards Reporting Trials ( CONSORT ) Standards Reporting Interventions Controlled Trials Acupuncture ( STRICTA ) . Asepsis ear alcohol 70 % necessary apply 4 5 auricular acupuncture point . In intervention group , specific point use management pain physical function . In placebo group , non-specific point use . Patients instruct exert finger pressure point 3 minute . At least 3x / day , whenever feel pain . These implant keep 5 day take participant 2 day next appointment . Ethical aspect : The research begin approval Ethics Research Committee ( CEP ) Federal University Ceará . All participant sign Informed Consent free withdraw study .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Chikungunya Fever</mesh_term>
	<criteria>individual age ≥ 18 year ; medical referral Family Health Strategy due symptom result Chikungunya fever confirm clinical laboratory criterion ; able understand instruction answer question ask interviewer . complaint pain unrelated low limb ; presence malignant neoplastic disease ; history traumatic injury lower limb surgery last 12 month ; congenital deformation ; pregnancy ; history treatment Auriculotherapy , acupuncture physiotherapy last four week ; use steroid medication last month ; use opioids study period ; sign Free Informed Consent Form ( TCLE ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chikungunya Fever</keyword>
	<keyword>Pain</keyword>
	<keyword>Mobility Limitation</keyword>
	<keyword>Auriculotherapy</keyword>
	<keyword>Complementary Therapies</keyword>
	<keyword>Physical Therapy</keyword>
</DOC>